Prognosis and staging in melanoma

Area of Science:

• Dermatology
• Oncology
• Pathology

Background:

• Primary cutaneous melanoma prognosis is influenced by multiple factors.
• Tumor thickness is the most significant prognostic indicator for primary cutaneous melanoma.
• Other factors like Clark's level, tumor histology (ulceration), site, age, and gender also impact prognosis.

Purpose of the Study:

• To identify key prognostic factors in primary cutaneous melanoma.
• To determine important prognostic features in regional lymph node metastases and distant metastatic disease.
• To guide cost-effective staging and follow-up strategies for melanoma patients.

Main Methods:

• Analysis of prognostic significance of tumor thickness, Clark's level, tumor histology, anatomic site, patient age, and gender.
• Evaluation of prognostic features for regional lymph node metastases (number of nodes, capsular invasion).
• Assessment of prognostic variables for distant metastatic disease (number and site of lesions).

Main Results:

• Tumor thickness is the primary prognostic factor in cutaneous melanoma.
• For metastatic disease, the number and site of lesions are critical.
• Extensive radiological staging is not cost-effective for primary melanoma; targeted imaging is recommended for positive nodes or metastases.
• Follow-up relies on history, physical exam, and chest X-ray, with advanced imaging reserved for suspected extensive disease.

Conclusions:

• Prognostic assessment in melanoma requires considering tumor thickness, metastatic site, and number of lesions.
• Staging and follow-up protocols should be tailored to patient risk, emphasizing cost-effectiveness.
• Early detection of recurrence is often achieved through basic clinical evaluation.